Structure of the C-terminal domains of merozoite surface protein-1 from Plasmodium knowlesi reveals a novel histidine binding site

被引:33
作者
Garman, SC
Simcoke, WN
Stowers, AW
Garboczi, DN
机构
[1] NIAID, Immunogenet Lab, Struct Biol Sect, NIH, Rockville, MD 20852 USA
[2] NIAID, Malaria Vaccine Dev Unit, Parasit Dis Lab, NIH, Rockville, MD 20852 USA
关键词
D O I
10.1074/jbc.M210716200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The protozoan parasite Plasmodium causes malaria, with hundreds of millions of cases recorded annually. Protection against malaria infection can be conferred by antibodies against merozoite surface protein (MSP)-1, making it an attractive vaccine candidate. Here we present the structure of the C-terminal domains of MSP-1 (known as MSP-1,9) from Plasmodium knowlesi. The structure reveals two tightly packed epidermal growth factor-like domains oriented head to tail. In domain 1, the molecule displays a histidine binding site formed primarily by a highly conserved tryptophan. The protein carries a pronounced overall negative charge primarily due to the large number of acidic groups in domain 2. To map protein binding surfaces on MSP-1(19), we have analyzed the crystal contacts in five different crystal environments, revealing that domain 1 is highly preferred in protein-protein interactions. A comparison of MSP-1(19), structures from P. knowlesi, P. cynomolgi, and P. falciparum shows that, although the overall protein folds are similar, the molecules show significant differences in charge distribution. We propose the histidine binding site in domain 1 as a target for inhibitors of protein binding to MSP-1, which might prevent invasion of the merozoite into red blood cells.
引用
收藏
页码:7264 / 7269
页数:6
相关论文
共 46 条
  • [31] FRAGMENTS OF THE POLYMORPHIC MR-185000 GLYCOPROTEIN FROM THE SURFACE OF ISOLATED PLASMODIUM-FALCIPARUM MEROZOITES FORM AN ANTIGENIC COMPLEX
    MCBRIDE, JS
    HEIDRICH, HG
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1987, 23 (01) : 71 - 84
  • [32] Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1
    Morgan, WD
    Birdsall, B
    Frenkiel, TA
    Gradwell, MG
    Burghaus, PA
    Syed, SEH
    Uthaipibull, C
    Holder, AA
    Feeney, J
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1999, 289 (01) : 113 - 122
  • [33] PROTEIN FOLDING AND ASSOCIATION - INSIGHTS FROM THE INTERFACIAL AND THERMODYNAMIC PROPERTIES OF HYDROCARBONS
    NICHOLLS, A
    SHARP, KA
    HONIG, B
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 1991, 11 (04) : 281 - 296
  • [34] Antibodies against merozoite surface protein (MSP)-119 are a major component of the invasion-inhibitory response in individuals immune to malaria
    O'Donnell, RA
    de Koning-Ward, TF
    Burt, RA
    Bockarie, M
    Reeder, JC
    Cowman, AF
    Crabb, BS
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (12) : 1403 - 1412
  • [35] Processing of X-ray diffraction data collected in oscillation mode
    Otwinowski, Z
    Minor, W
    [J]. MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 : 307 - 326
  • [36] STRUCTURE OF HUMAN DES(1-45) FACTOR-XA AT 2.2-ANGSTROM RESOLUTION
    PADMANABHAN, K
    PADMANABHAN, KP
    TULINSKY, A
    PARK, CH
    BODE, W
    HUBER, R
    BLANKENSHIP, DT
    CARDIN, AD
    KISIEL, W
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1993, 232 (03) : 947 - 966
  • [37] PERKINS ME, 1988, J IMMUNOL, V141, P3190
  • [38] Crystallization and preliminary structural analysis of an antibody complex formed with PfMSP1-19, a malaria vaccine candidate
    Pizarro, JC
    Chitarra, V
    Calvet, C
    Verger, D
    Bentley, GA
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 : 1246 - 1248
  • [39] NATURALLY ACQUIRED CELLULAR AND HUMORAL IMMUNE-RESPONSES TO THE MAJOR MEROZOITE SURFACE-ANTIGEN (PFMSP1) OF PLASMODIUM-FALCIPARUM ARE ASSOCIATED WITH REDUCED MALARIA MORBIDITY
    RILEY, EM
    ALLEN, SJ
    WHEELER, JG
    BLACKMAN, MJ
    BENNETT, S
    TAKACS, B
    SCHONFELD, HJ
    HOLDER, AA
    GREENWOOD, BM
    [J]. PARASITE IMMUNOLOGY, 1992, 14 (03) : 321 - 337